| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Juan Marcos Gonzalez Sepulveda, Jui-Chen Yang, Alicja Mastylak, Elaine M Wells-Gray, Landon Grace, Stephen Franse. Quantifying Patient Preferences and Expectations About Diabetic Retinopathy Monitoring. JAMA ophthalmology. 2024-12-19. PMID:39699904. |
diabetic retinopathy (dr) is the leading cause of blindness among adults in the us. |
2024-12-19 |
2024-12-21 |
Not clear |
| Xingchen Zhou, Guixue Hou, Xin Wang, Zhaoyi Peng, Xiaoming Yin, Jing Yang, Shan Wang, Yayi He, Yue Wang, Jing Sui, Wei Qiang, Hui Guo, Yanan Wang, Liang Lin, Bingyin Shi, Mingqian H. Metabolomic studies reveal and validate potential biomarkers of diabetic retinopathy in two Chinese datasets with type 2 diabetes: a cross-sectional study. Cardiovascular diabetology. vol 23. issue 1. 2024-12-19. PMID:39696333. |
diabetic retinopathy (dr) is a major microvascular complication of diabetes mellitus and causes vision impairment and blindness. |
2024-12-19 |
2024-12-21 |
Not clear |
| Ryan Emmert, Mackenzee Thompson, Dawsyn Smith, Riley Marlar, Kristen McPherson, Simran Demla, Micah Hartwel. Prevalence of Diabetic Retinopathy and Dilated Fundus Examinations by Metropolitan Status from 2017-2021: An Assessment of the Behavioral Risk Factor Surveillance System. Ophthalmic epidemiology. 2024-12-18. PMID:39693586. |
diabetic eye disease, namely diabetic retinopathy (dr), remains a leading cause of preventable blindness worldwide. |
2024-12-18 |
2024-12-21 |
Not clear |
| Jun-Sik Kim, Jae Hyun Jun, Jeongmi Lee, Sunyoung Park, Eunae Kim, Su Jung Hwang, Heesu Moon, Seung Hyun Baek, Hark Kyun Kim, Jinsu Park, Yoonsuk Cho, Jihoon Han, Chanhee Kim, Jongho Kim, Hyun-Mo Yang, Changsik Lee, Yeonseok Chung, Hyo-Jong Lee, Dong-Gyu J. HDAC6 mediates NLRP3 inflammasome activation in the pathogenesis of diabetic retinopathy. Metabolism: clinical and experimental. 2024-12-17. PMID:39689826. |
diabetic retinopathy (dr), a major blindness cause in developed countries, is intricately linked to diabetes management and its duration. |
2024-12-17 |
2024-12-21 |
Not clear |
| Marianthi Ntikoudi, Theofano Myrto Farmaki, Konstantinos Tziomalo. Dopamine: A New Player in the Pathogenesis of Diabetic Retinopathy? International journal of molecular sciences. vol 25. issue 23. 2024-12-17. PMID:39684908. |
diabetic retinopathy (dr) is a leading cause of blindness. |
2024-12-17 |
2024-12-21 |
Not clear |
| Huma Naz, Neelu Jyothi Ahuj. A novel contrast enhancement technique for diabetic retinal image pre-processing and classification. International ophthalmology. vol 45. issue 1. 2024-12-16. PMID:39680225. |
diabetic retinopathy (dr) is a leading cause of blindness among individuals aged 18 to 65 with diabetes, affecting 35-60% of this population, according to the international diabetes federation. |
2024-12-16 |
2024-12-21 |
Not clear |
| Sundreen Asad Kamal, Youtian Du, Majdi Khalid, Majed Farrash, Sahraoui Dheli. DRSegNet: A cutting-edge approach to Diabetic Retinopathy segmentation and classification using parameter-aware Nature-Inspired optimization. PloS one. vol 19. issue 12. 2024-12-05. PMID:39637079. |
diabetic retinopathy (dr) is a prominent reason of blindness globally, which is a diagnostically challenging disease owing to the intricate process of its development and the human eye's complexity, which consists of nearly forty connected components like the retina, iris, optic nerve, and so on. |
2024-12-05 |
2024-12-08 |
human |
| Qiwei Fan, Shanshan Feng, Jianrong Chen, Yan Zhang, Jixiong Xu, Jiancheng Wan. An Association between Bilirubin and Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus: An Effect Modification by Nrf2 Polymorphisms. Current diabetes reviews. 2024-12-02. PMID:39620335. |
diabetic retinopathy (dr) is a persistent microvascular complication associated with diabetes, and it constitutes a significant cause of visual impairment and blindness. |
2024-12-02 |
2024-12-06 |
Not clear |
| Ying Yan. YAP1 overexpression aggravates the progress of diabetic retinopathy by activating the TUG1/miR-144-3p/VEGFA signaling pathway in the hypoxia-induced DR MRMECs model. Tissue & cell. vol 92. 2024-11-30. PMID:39615227. |
diabetic retinopathy (dr) has been proven to be a leading cause of blindness. |
2024-11-30 |
2024-12-06 |
mouse |
| Caoxin Huang, Xiaofang Zhang, Menghua Wu, Chen Yang, Xilin Ge, Wenting Chen, Xuejun Li, Suhuan Liu, Shuyu Yan. IL-1β-induced pericyte dysfunction with a secretory phenotype exacerbates retinal microenvironment inflammation via Hes1/STAT3 signaling pathway. International immunopharmacology. vol 144. 2024-11-29. PMID:39612772. |
pericyte loss has been considered as the hallmark of diabetic retinopathy (dr), which is a major complication of diabetes and the leading cause of blindness in adults. |
2024-11-29 |
2024-12-02 |
Not clear |
| Dimple Saproo, Aparna N Mahajan, Seema Narwa. Deep learning based binary classification of diabetic retinopathy images using transfer learning approach. Journal of diabetes and metabolic disorders. vol 23. issue 2. 2024-11-29. PMID:39610484. |
diabetic retinopathy (dr) is a common problem of diabetes, and it is the cause of blindness worldwide. |
2024-11-29 |
2024-12-01 |
Not clear |
| Nasrin Amiri-Dashatan, Samira Motedayen Etemadi, Shahin Besharati, Masoumeh Farahani, Arezoo Karimi Moghadda. Dysregulation of amino acids balance as potential serum-metabolite biomarkers for diagnosis and prognosis of diabetic retinopathy: a metabolomics study. Journal of diabetes and metabolic disorders. vol 23. issue 2. 2024-11-29. PMID:39610496. |
diabetic retinopathy (dr), an earnest complication of diabetes, is one of the most common causes of blindness worldwide. |
2024-11-29 |
2024-12-01 |
human |
| Feyisa Shasho Bayisa, Teshome Demis Nimani, Samuel Demissie Darch. Prevalence and its associated factors of diabetic retinopathy among type 1 and type 2 diabetic patients at public hospitals in Eastern Ethiopia, 2023: a hospital-based comparative cross-sectional study. Frontiers in clinical diabetes and healthcare. vol 5. 2024-11-29. PMID:39611059. |
diabetic retinopathy (dr) is a highly prevalent microvascular disease among diabetic patients, resulting in irreversible blindness. |
2024-11-29 |
2024-12-01 |
Not clear |
| Khaled Elmasry, Samar Habib, Inas Helwa, Mariam Lotfy Khaled, Ahmed S Ibrahim, Amany Tawfik, Mohamed Al-Shabrawe. Possible Role of Endothelial-Derived Cellular and Exosomal-miRNAs in Lipid-Mediated Diabetic Retinopathy: Microarray Studies. Cells. vol 13. issue 22. 2024-11-27. PMID:39594634. |
diabetic retinopathy (dr) is a salient cause of blindness worldwide. |
2024-11-27 |
2024-11-29 |
mouse |
| Liji Menon M, Neeraj V Mohandas, Tara Susan Mohan, Neethu George, Vinod Mohandas, Malavika C K, Saji Subramania. Awareness of Diabetic Retinopathy Among Patients With Diabetes Mellitus in the Ernakulam District, South India: A Hospital-Based Cross-Sectional Study. Cureus. vol 16. issue 10. 2024-11-15. PMID:39544614. |
diabetic retinopathy (dr) is a major microvascular complication of diabetes, leading to blindness. |
2024-11-15 |
2024-11-17 |
human |
| Rida Shahzad, Arshad Mehmood, Danish Shabbir, M A Rehman Siddiqu. Diagnostic accuracy of a smartphone-based device (VistaView) for detection of diabetic retinopathy: A prospective study. PLOS digital health. vol 3. issue 11. 2024-11-08. PMID:39514591. |
diabetic retinopathy (dr) is a leading cause of blindness globally. |
2024-11-08 |
2024-11-16 |
Not clear |
| Wentao Sun, Rui Wang, Ke Gong, Liping Wang, Fengzhi Li, Jin Den. Paeoniflorin-mediated downregulation of VEGFA: unveiling the therapeutic mechanism of buyang huanwu decoction in diabetic retinopathy. Naunyn-Schmiedeberg's archives of pharmacology. 2024-11-07. PMID:39508875. |
diabetic retinopathy (dr) is a leading cause of blindness globally. |
2024-11-07 |
2024-11-16 |
Not clear |
| N Ramshankar, S Murugesan, Praveen K V, P M Joe Pratha. Coinciding Diabetic Retinopathy and Diabetic Macular Edema Grading With Rat Swarm Optimization Algorithm for Enhanced Capsule Generation Adversarial Network. Microscopy research and technique. 2024-11-02. PMID:39487733. |
in the worldwide working-age population, visual disability and blindness are common conditions caused by diabetic retinopathy (dr) and diabetic macular edema (dme). |
2024-11-02 |
2024-11-05 |
rat |
| N Ramshankar, S Murugesan, Praveen K V, P M Joe Pratha. Coinciding Diabetic Retinopathy and Diabetic Macular Edema Grading With Rat Swarm Optimization Algorithm for Enhanced Capsule Generation Adversarial Network. Microscopy research and technique. 2024-11-02. PMID:39487733. |
among these, dr and dme are the two foremost eye diseases, the severity of which may lead to some eye-related problems and blindness. |
2024-11-02 |
2024-11-05 |
rat |
| Patricia Bai, Cameron Beversluis, Amy Song, Nylani Alicea, Yuval Eisenberg, Brian Layden, Angelica Scanzera, Ariel Leifer, Hugh Musick, Robison Vernon Paul Cha. Opportunities to Apply Human-centered Design in Health Care With Artificial Intelligence-based Screening for Diabetic Retinopathy. International ophthalmology clinics. vol 64. issue 4. 2024-10-31. PMID:39480202. |
diabetic retinopathy (dr) is a leading cause of blindness. |
2024-10-31 |
2024-11-02 |
Not clear |